ボツリヌス毒素の世界市場レポート 2024

ボツリヌス毒素の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には9.2%の年間平均成長率（CAGR）で105億3,000万米ドルに成長すると予想されています。予測期間中に予想される成長は、美容医療市場の拡大、製剤と送達方法の進歩、治療用途の多様化、世界の高齢化、新興市場での需要の増加、患者の増加など、いくつかの重要な要因に起因すると考えられます。認識と受け入れ、そして全体的な世界市場の拡大。これらの要因により、ボツリヌス毒素アプリケーションの継続的な成長が促進されると予想されます。予測期間中に予想される主な動向には、業界内の戦略的提携、個別化された精密医療アプローチの採用、新しい適応症に対する規制当局の承認、進行中の製品革新などが含まれます。これらの動向は、治療効果や安全性の向上、より幅広い医療および美容上のニーズへの対応に焦点を当てた、ボツリヌス毒素アプリケーションの進化する情勢を反映しています。

審美的処置に対する需要の高まりにより、予見可能な将来、ボツリヌス毒素市場の拡大が大幅に促進されると予測されています。審美的処置には、外科的手段または非外科的手段によって、個人の外観を洗練することを目的としたさまざまな美容処置が含まれます。これらの手順で一般的に使用されるボツリヌス毒素は、特定の筋肉を効果的に弛緩させ、しわや小じわを目立たなくします。たとえば、2021年に米国美容形成外科学会が発行した美容形成外科統計報告書によると、この分野の外科活動は大幅に増加しました。 2020年に形成外科医が行った平均手術件数（220件）と2021年（320件）を比較すると、注目すべき増加が浮き彫りとなり、美容治療の需要が堅調に増加していることを示しています。その結果、審美的処置に対する需要の高まりが、ボツリヌス毒素市場の成長の原動力として浮上しています。

世界の高齢化人口の急増により、今後数年間でボツリヌス毒素市場の拡大が促進されると予想されます。「高齢化人口」という用語は、社会における高齢者の割合の増加を特徴とする人口動態の変化を指します。 ボツリヌス毒素は、しわや小じわに対処するために高齢化人口に広く受け入れられている人気の低侵襲ソリューションとして際立っており、顔の美しさを高め、より若々しい外観を実現するための非外科的手段を提供します。 2022年 10月に世界保健機関（WHO）が報告したように、世界の60歳以上の人口は急速な増加軌道にあり、2050年までに倍増して推定21億人に達すると予測されています。この高齢化人口への人口動態の変化は、ボツリヌス毒素施術に対する需要の増加に大きく寄与し、それによってボツリヌス毒素市場の成長を推進します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のボツリヌス毒素市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• A型ボツリヌス毒素
• B型ボツリヌス毒素
• 世界のボツリヌス毒素市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 治療
• 美容
• 世界のボツリヌス毒素市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• 専門クリニック
• 皮膚科クリニック
• その他のエンドユーザー

第7章 地域および国の分析

• 世界のボツリヌス毒素市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界のボツリヌス毒素市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ボツリヌス毒素市場の競合情勢
• ボツリヌス毒素市場の企業プロファイル
  • Cigna Group
  • Pfizer Inc.
  • AbbVie Inc.
  • Teijin Pharma Ltd.
  • Eisai Co. Ltd.

第31章 その他の大手および革新的な企業

• Menarinin Group
• Ipsen Group
• Galderma SA
• Daewoong Pharmaceuticals Co. Ltd.
• Supernus Pharmaceuticals Inc.
• Merz Pharma GmbH &Co. KGaA
• Hugel Inc.
• Evolus Inc.
• Medytox Inc.
• Revance Therapeutics Inc.
• Sinclair Pharma
• US WorldMeds LLC
• Hugh Source International Ltd.
• MedivaPharma
• Wigmore Medical

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Botulinum toxin, commonly known as Botox, is a neurotoxic protein produced by the bacterium Clostridium botulinum, recognized as one of the most potent toxins known to humans. Its applications span both medical and cosmetic purposes, encompassing the treatment of muscle spasms, reduction of wrinkles, management of excessive sweating, and addressing specific eye and bladder disorders.

The primary types of botulinum toxins include botulinum toxin type A and botulinum toxin type B. Botulinum toxin type A is a neurotoxic protein produced by Clostridium botulinum, widely utilized in various medical and cosmetic procedures. These applications extend to both therapeutic and aesthetic uses, with diverse end-users such as hospitals, specialty clinics, dermatology clinics, and others.

The botulinum toxins market research report is one of a series of new reports from The Business Research Company that provides botulinum toxins market statistics, including botulinum toxins industry global market size, regional shares, competitors with a botulinum toxins market share, detailed botulinum toxins market segments, market trends, and opportunities, and any further data you may need to thrive in the botulinum toxins industry. This botulinum toxins market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The botulinum toxin market size has grown rapidly in recent years. It will grow from $6.72 billion in 2023 to $7.4 billion in 2024 at a compound annual growth rate (CAGR) of 10.1%. The growth observed during the historical period can be attributed to various factors, including the widespread adoption of botulinum toxin for cosmetic applications, its utilization in various medical therapies, the expansion of the field of aesthetic medicine, increased awareness and acceptance of these treatments, and ongoing research and development initiatives. These factors collectively contributed to the historical growth of botulinum toxin applications in both cosmetic and medical settings.

The botulinum toxin market size is expected to see strong growth in the next few years. It will grow to $10.53 billion in 2028 at a compound annual growth rate (CAGR) of 9.2%. The anticipated growth in the forecast period can be attributed to several key factors, including the expansion of the aesthetic medicine market, advancements in formulations and delivery methods, the diversification of therapeutic applications, the global aging population, increasing demand in emerging markets, growing patient awareness and acceptance, and overall global market expansion. These factors are expected to drive the continued growth of botulinum toxin applications. Major trends expected in the forecast period include strategic collaborations within the industry, the adoption of personalized and precision medicine approaches, regulatory approvals for new indications, and ongoing product innovations. These trends reflect the evolving landscape of botulinum toxin applications, with a focus on enhancing therapeutic efficacy, safety, and addressing a broader range of medical and cosmetic needs.

The escalating demand for aesthetic procedures is projected to significantly boost the expansion of the botulinum toxin market in the foreseeable future. Aesthetic procedures encompass various cosmetic treatments aimed at refining an individual's appearance, whether through surgical or non-surgical means. Botulinum toxin, commonly utilized in these procedures, effectively relaxes specific muscles, diminishing the visibility of wrinkles and fine lines. For instance, as per the Aesthetic Plastic Surgery statistical report published by The American Society for Aesthetic Plastic Surgery in 2021, there was a substantial surge in surgical activity within the field. Comparing the average number of surgical procedures performed by plastic surgeons in 2020 (220 procedures) to 2021 (320 procedures) highlights a noteworthy increase, signaling a robust uptick in demand for aesthetic treatments. Consequently, the heightened demand for aesthetic procedures emerges as a driving force behind the growth of the botulinum toxin market.

The burgeoning global aging population is anticipated to propel the expansion of the botulinum toxin market in the coming years. The term 'aging population' refers to a demographic shift characterized by a growing proportion of elderly individuals within a society. Botulinum toxin stands out as a popular and minimally invasive solution widely embraced by the aging population to address wrinkles and fine lines, offering a non-surgical avenue to enhance facial aesthetics and attain a more youthful appearance. As reported by the World Health Organization (WHO) in October 2022, the worldwide population aged 60 years and older is on a rapid growth trajectory, projected to double by 2050, reaching an estimated 2.1 billion individuals. This demographic shift towards an increasingly elderly population significantly contributes to the rising demand for botulinum toxin procedures, thereby propelling the growth of the botulinum toxin market.

Product innovation stands out as a prominent trend driving advancements in the botulinum toxin market, with companies actively pursuing innovative solutions to maintain their market positions. An illustration of this trend is evident in the developments by Evolus Inc., a US-based medical aesthetics company, which obtained approval from the Australian Therapeutic Goods Administration (TGA) in January 2023 for Nuceiva (prabotulinumtoxin A) in Australia. Nuceiva, containing botulinum toxin type A, is specifically designed for aesthetic purposes, aimed at temporarily enhancing the appearance of moderate glabellar lines in adult patients. The product functions by interrupting nerve impulses within facial muscles, inducing relaxation, and effectively smoothing wrinkles resulting from facial expressions such as squinting and frowning.

Major players in the botulinum toxin market are focusing on groundbreaking product innovations, exemplified by the introduction of robotic syringes, to offer customers enhanced and reliable services. One such instance is showcased by Juvaplus SA, a Switzerland-based provider, which launched Juvapen Expert for botulinum toxin in August 2021. The Juvapen Expert integrates the precision and control of a robotic arm with traditional syringe functionality. The technology facilitates precise toxin delivery in minute doses, as low as 0.005ml, reducing the likelihood of over- or under-injection. The automated process also contributes to expedited injection times, improving efficiency for both practitioners and patients. Additionally, the robotic delivery mechanism mitigates risks associated with manual injections, such as needle sticks and tissue damage, enhancing overall safety during the procedure.

In August 2021, Merz Pharma GmbH & Co. KGaA, a pharmaceutical company based in Germany, entered into a collaboration with Vensica Therapeutics Ltd. The collaboration aimed to explore the administration of botulinum neurotoxin-A (Xeomin) to the bladder wall utilizing Vensica's innovative ultrasound-assisted administration catheter. Vensica Therapeutics Ltd., headquartered in Israel, is a company specializing in the design and development of urology catheters and medication delivery systems. This collaboration represented a strategic partnership between the two companies to advance the delivery methods of botulinum neurotoxin-A for potential therapeutic applications in urology.

Major companies operating in the botulinum toxin market report are Cigna Group, Pfizer Inc., AbbVie Inc., Teijin Pharma Ltd., Eisai Co. Ltd., Menarinin Group, Ipsen Group, Galderma S.A., Daewoong Pharmaceuticals Co. Ltd., Supernus Pharmaceuticals Inc., Merz Pharma GmbH & Co. KGaA, Hugel Inc., Evolus Inc., Medytox Inc., Revance Therapeutics Inc., Sinclair Pharma, US WorldMeds LLC, Hugh Source International Ltd., MedivaPharma, Wigmore Medical, AesthetiCare, Lanzhou Institute of Biological Products Co Ltd., AestheticSource, Botox Cosmetic, Metabiologics Inc.

North America was the largest region in the botulinum toxin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the botulinum toxin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the botulinum toxin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The botulinum toxin market consists of sales of botulinum toxin C and botulinum toxin D and their related formulations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Botulinum Toxin Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on botulinum toxin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for botulinum toxin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The botulinum toxin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Botulinum Toxin Type A; Botulinum Toxin Type B
• 2) By Application: Therapeutics; Aesthetics
• 3) By End User: Hospitals; Specialty Clinics; Dermatology Clinics; Other End Users
• Companies Mentioned: Cigna Group; Pfizer Inc.; AbbVie Inc.; Teijin Pharma Ltd.; Eisai Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Botulinum Toxin Market Characteristics

3. Botulinum Toxin Market Trends And Strategies

4. Botulinum Toxin Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Botulinum Toxin Market Size and Growth

• 5.1. Global Botulinum Toxin Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Botulinum Toxin Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Botulinum Toxin Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Botulinum Toxin Market Segmentation

• 6.1. Global Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Botulinum Toxin Type A
• Botulinum Toxin Type B
• 6.2. Global Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Therapeutics
• Aesthetics
• 6.3. Global Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Specialty Clinics
• Dermatology Clinics
• Other End Users

7. Botulinum Toxin Market Regional And Country Analysis

• 7.1. Global Botulinum Toxin Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Botulinum Toxin Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Botulinum Toxin Market

• 8.1. Asia-Pacific Botulinum Toxin Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Botulinum Toxin Market

• 9.1. China Botulinum Toxin Market Overview
• 9.2. China Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Botulinum Toxin Market

• 10.1. India Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Botulinum Toxin Market

• 11.1. Japan Botulinum Toxin Market Overview
• 11.2. Japan Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Botulinum Toxin Market

• 12.1. Australia Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Botulinum Toxin Market

• 13.1. Indonesia Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Botulinum Toxin Market

• 14.1. South Korea Botulinum Toxin Market Overview
• 14.2. South Korea Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Botulinum Toxin Market

• 15.1. Western Europe Botulinum Toxin Market Overview
• 15.2. Western Europe Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Botulinum Toxin Market

• 16.1. UK Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Botulinum Toxin Market

• 17.1. Germany Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Botulinum Toxin Market

• 18.1. France Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Botulinum Toxin Market

• 19.1. Italy Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Botulinum Toxin Market

• 20.1. Spain Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Botulinum Toxin Market

• 21.1. Eastern Europe Botulinum Toxin Market Overview
• 21.2. Eastern Europe Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Botulinum Toxin Market

• 22.1. Russia Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Botulinum Toxin Market

• 23.1. North America Botulinum Toxin Market Overview
• 23.2. North America Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Botulinum Toxin Market

• 24.1. USA Botulinum Toxin Market Overview
• 24.2. USA Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Botulinum Toxin Market

• 25.1. Canada Botulinum Toxin Market Overview
• 25.2. Canada Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Botulinum Toxin Market

• 26.1. South America Botulinum Toxin Market Overview
• 26.2. South America Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Botulinum Toxin Market

• 27.1. Brazil Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Botulinum Toxin Market

• 28.1. Middle East Botulinum Toxin Market Overview
• 28.2. Middle East Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Botulinum Toxin Market

• 29.1. Africa Botulinum Toxin Market Overview
• 29.2. Africa Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Botulinum Toxin Market Competitive Landscape And Company Profiles

• 30.1. Botulinum Toxin Market Competitive Landscape
• 30.2. Botulinum Toxin Market Company Profiles
  • 30.2.1. Cigna Group
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Pfizer Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. AbbVie Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Teijin Pharma Ltd.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Eisai Co. Ltd.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Botulinum Toxin Market Other Major And Innovative Companies

• 31.1. Menarinin Group
• 31.2. Ipsen Group
• 31.3. Galderma S.A.
• 31.4. Daewoong Pharmaceuticals Co. Ltd.
• 31.5. Supernus Pharmaceuticals Inc.
• 31.6. Merz Pharma GmbH & Co. KGaA
• 31.7. Hugel Inc.
• 31.8. Evolus Inc.
• 31.9. Medytox Inc.
• 31.10. Revance Therapeutics Inc.
• 31.11. Sinclair Pharma
• 31.12. US WorldMeds LLC
• 31.13. Hugh Source International Ltd.
• 31.14. MedivaPharma
• 31.15. Wigmore Medical

32. Global Botulinum Toxin Market Competitive Benchmarking

33. Global Botulinum Toxin Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Botulinum Toxin Market

35. Botulinum Toxin Market Future Outlook and Potential Analysis

• 35.1 Botulinum Toxin Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Botulinum Toxin Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Botulinum Toxin Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer